At the news
? NEUTRALIMPACT 2/10 6-K filed Jul 15, 2026 at 16:57 ET
Ascendis Pharma filed a 6-K reporting the grant of 14,060 warrants to employees at an exercise price of $265.57 per share, with standard time-based vesting (25% after one year, 75% monthly thereafter). The filing also updates the company's Articles of Association to reflect this grant. This is a routine employee compensation event with no material financial impact.
- 14,060 warrants granted to employees on July 14, 2026
- Exercise price of $265.57 per share (closing price on grant date)
- Warrants vest 25% after one year, remaining 75% over 36 months
- After this grant, 1,539,503 shares remain available for future warrant grants
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access